Oncovana
Digital platform coordinating fertility preservation for cancer patients.
Website: https://www.oncovana.com
Cover Block
| Attribute | Value |
|---|---|
| Name | Oncovana |
| Tagline | Digital platform coordinating fertility preservation for cancer patients. |
| Founded | 2024 |
| Stage | Pre-Seed |
| Business Model | B2B2C |
| Industry | Healthtech |
| Technology | Software (Non-AI) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding Label | Undisclosed |
Links
- Website. https://www.oncovana.com [Oncovana]
The Short Version
Oncovana is a pre-revenue digital health platform that coordinates fertility preservation for newly diagnosed cancer patients [American Bazaar Online, November 2024]. The company originated from a George Washington University entrepreneurship course in February 2024, launched by a team of DrPH students [American Bazaar Online, November 2024]. Its proposed software platform connects patients, oncology teams, and fertility clinics to streamline education and access to preservation procedures [Oncovana.com, 2024]. The company has participated in the Halcyon Accelerator but has no announced funding rounds. Critical milestones include securing initial hospital or cancer center partnerships and articulating a clear B2B2C revenue model.
Data Accuracy: YELLOW -- Core company description is confirmed by its website and university coverage; market sizing and team details rely on a single niche publication.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Pre-Seed |
| Business Model | B2B2C |
| Industry / Vertical | Healthtech |
| Technology Type | Software (Non-AI) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
The Company in Brief
Oncovana is a digital health venture that emerged from a George Washington University entrepreneurship course in February 2024, conceived by a team of DrPH students at the Milken Institute School of Public Health [American Bazaar Online, November 2024]. The founding team includes Bhakthi Sahgal, John Russell, Bridget Kelly, Alvaro Rivera, and Ornsiree Junchaya [American Bazaar Online, November 2024]. The company's public narrative centers on this academic origin and its selection for the Halcyon Accelerator program [Halcyon Accelerator].
Data Accuracy: YELLOW -- Company details and founding story corroborated by university and accelerator sources; legal and operational details are not publicly verified.
What They Have Built
Oncovana is building a digital coordination platform for oncofertility care. The product acts as a hub connecting oncology care teams, fertility clinics, and patients to streamline education, resource navigation, and access to fertility preservation [Oncovana.com, GW Today]. The platform focuses on workflow and information management rather than novel AI or clinical technology [Halcyon Accelerator].
Data Accuracy: YELLOW -- Product claims are consistent across the company website and university press, but feature specifics and technical architecture are not detailed.
Market Research and Opportunity
Oncovana's market sizing is anchored on a $16 billion figure for the broader fertility market [American Bazaar Online, November 2024]. Its serviceable obtainable market is defined by the approximately 2 million patients newly diagnosed with cancer each year in the United States [American Bazaar Online, November 2024]. Demand is driven by improved cancer survival rates and the 2018 American Society of Clinical Oncology (ASCO) guideline update, which recommends discussing infertility risks with reproductive-age patients at diagnosis.
| Metric | Value |
|---|---|
| Total Fertility Market (Analog) | 16 $B |
| Annual New Cancer Diagnoses (US) | 2 million patients |
Data Accuracy: YELLOW -- Market sizing figures are cited in a single media profile; the 2M patient statistic aligns with general oncology epidemiology but requires further sourcing.
Who Else Is Fighting for This
Oncovana faces a fragmented ecosystem of adjacent services and manual processes rather than direct, named competitors. The competitive map includes general fertility platforms like Kindbody and Progyny, oncology-focused digital health tools, and the incumbent process of disconnected phone calls and faxed referrals [American Bazaar Online, November 2024]. Oncovana's differentiation hinges on its specialized focus on the oncology care pathway.
Data Accuracy: YELLOW -- Competitive analysis is inferred from market structure; no direct competitors are named in public sources.
Opportunity
Oncovana aims to become the default coordination layer for oncofertility care. By linking oncology teams, fertility clinics, and patients, it seeks to solve a time-sensitive clinical coordination problem. Success would position the company as a gatekeeper for patient referrals in a high-value segment of the $16 billion fertility market [American Bazaar Online, November 2024].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Academic Medical Center Adoption | Oncovana is adopted as the standard referral tool within a major cancer center or hospital network. | A pilot partnership with a named oncology department, likely facilitated through the founders' academic connections at George Washington University or the Halcyon Accelerator network [Halcyon Accelerator]. | The platform addresses a documented care coordination gap, and its origin in a public health academic setting aligns with the research and quality improvement goals of teaching hospitals. |
| Fertility Clinic Network Partnership | A large fertility clinic chain (e.g., Kindbody, Shady Grove Fertility) integrates Oncovana as its dedicated intake channel for oncology referrals. | A commercial agreement with a clinic network seeking to streamline and grow its oncofertility patient volume. | Fertility clinics have a direct economic incentive to secure predictable, qualified patient referrals; a digital platform that pre-vets and educates patients reduces administrative friction. |
Data Accuracy: YELLOW -- Market size and patient population figures are from a single niche publication; company stage and model are confirmed by its website and university coverage.
Sources
- [Oncovana, 2024] Oncovana, https://www.oncovana.com
- [American Bazaar Online, November 2024] Oncovana: A new frontier in fertility support for cancer patients, https://americanbazaaronline.com/2024/11/02/oncovana-in-fertility-support-for-cancer-patients-456870/
- [GW Today, 2024] What’s the Big Idea? Oncovana Guides Cancer Patients to Fertility Preservation Options, https://gwtoday.gwu.edu/whats-big-idea-oncovana-guides-cancer-patients-fertility-preservation-options
- [Halcyon Accelerator] Oncovana | Halcyon, https://halcyonaccelerator.org/venture/oncovana/
Articles about Oncovana
- Oncovana Is Building a Digital Bridge for Cancer Patients to Fertility Clinics — A team of George Washington University DrPH students is targeting an overlooked gap in oncology care, aiming to coordinate fertility preservation for two million newly diagnosed patients annually.